Live from the NIH registry
Studies recruiting near Dayton right now
Top 25 of 308 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Miami Valley Hospital South — Centerville, Ohio (10.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Children's Oncology Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Hometown Urgent Care and Research - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Crystalys Therapeutics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro — Springboro, Ohio (15.9 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Good Samaritan Hospital - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis and Rheumatology of Southwest Ohio — Liberty Township, Ohio (28.1 mi)
· Sponsor: University of Alabama at Birmingham
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 120 participants sought
The Children's Medical Center of Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Stat Research — Miamisburg, Ohio (10.6 mi)
· Sponsor: Amgen
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
304 — Centerville, Ohio (10.7 mi)
· Sponsor: Corcept Therapeutics
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 750 participants sought
Dayton Physicians LLC Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Amgen
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Photosensitivity, Microvesicle Particle
Phase 1
Interventional 40 participants sought
Wright State Physicians — Fairborn, Ohio (10.0 mi)
· Sponsor: Wright State University
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Centerville, OH Investigative Site 10119 — Centerville, Ohio (10.7 mi)
· Sponsor: Colorado Prevention Center
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Nicole Hamblett
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Beavercreek, Ohio (8.8 mi)
· Sponsor: Xencor, Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Heart House Research Foundation LLC — Springfield, Ohio (23.0 mi)
· Sponsor: Duke University
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7081 — Dayton, Ohio (1.6 mi)
· Sponsor: Galderma R&D
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1122 — Dayton, Ohio (1.6 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Cincinnati Eye Institute — Mason, Ohio (29.6 mi)
· Sponsor: Dompé Farmaceutici S.p.A
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Springboro, Ohio (15.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Phase 2
Interventional 200 participants sought
Providence Health Partners-Center for Clinical Research — Dayton, Ohio (1.6 mi)
· Sponsor: Eli Lilly and Company